PD-L1 expression in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.

被引：0
|
作者：
Mamesaya, Nobuaki
Kenmotsu, Hirotsugu
Miyawaki, Eriko
Kotake, Mie
Kawamura, Takahisa
Kobayashi, Haruki
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20530
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [32] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [33] PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy
    Vrankar, M.
    Zwitter, M.
    Kern, I
    Stanic, K.
    NEOPLASMA, 2018, 65 (01) : 140 - 146
  • [34] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
  • [36] Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer.
    Rizvi, Hira
    Bandlamudi, Chaitanya
    Schoenfeld, Adam Jacob
    Sauter, Jennifer L.
    Arbour, Kathryn Cecilia
    Beras, Amanda
    Egger, Jacklynn V.
    Ladanyi, Marc
    Donoghue, Mark
    Rudin, Charles M.
    Taylor, Barry S.
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] PD-L1 and molecular biomarker expression in non-small cell lung cancer in Tunisian patients
    Houcine, Yoldez
    Moussa, Chirine
    Ben Abdelaziz, Ahmed
    Ayadi, Aida
    MONALDI ARCHIVES FOR CHEST DISEASE, 2024, 94 (04)
  • [38] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Efficacy of Chemo-Radiotherapy (CRT) in Stage III Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression
    Adam, Julien
    Boros, Angela
    Lacas, Benjamin
    Lacroix, Ludovic
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    Besse, Benjamin
    Le Pechoux, Cecile
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S244 - S244
  • [40] Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer
    Garassino, Marina C.
    Paz-Ares, Luis
    Hui, Rina
    Faivre-Finn, Corinne
    Spira, Alex
    Planchard, David
    Ozguroglu, Mustafa
    Daniel, Davey
    Vicente, David
    Murakami, Shuji
    Langer, Corey
    Senan, Suresh
    Spigel, David
    Ryden, Anna
    Zhang, Yiduo
    O'Brien, Cathy
    Dennis, Phillip A.
    Antonia, Scott J.
    FUTURE ONCOLOGY, 2021, 17 (10) : 1165 - 1184
12345